Intervention
EB-SELECT Single-Target CAR-NK Cells
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
1 shownCommon conditions
Acute Myeloid Leukemia (AML)1Breast Cancer1Cancer1Colorectal Cancer (Locally Advanced or Metastatic)1Glioblastoma1Liver Cancer1Melanoma (Skin Cancer)1Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma1Non Hodgkin Lymphoma1Non-Small Cell Lung Cancer (NSCLC)1Ovarian Cancer1Pancreatic Ductal Adenocarcinoma (PDAC)1Prostate Cancer - Recurrent1
Leading sponsors
Trial status mix
RECRUITING1
Phase mix
PHASE11
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.